Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1358-1362

  Blackburn, Robert V ^a   Galoforo, Sandra S ^a   Corry, Peter M ^a   Lee, Yong J ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE; GANCICLOVIR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; GENE FUSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; PRIORITY JOURNAL; PROSTATE CARCINOMA; VIRUS RECOMBINANT;

EID: 0032053744     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J. Sci. Am., 3: 78-87, 1997.
2. 1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? Int. J. Radiat. Oncol. Biol. Phys., 38: 723-729, 1997.
3. Hanks, G. E., Hanlon, A. L., Schultheiss, T. E., Freedman, G. M., Hunt, M., Pinover, W. H., and Movsas, B. Conformal external beam treatment of prostate cancer. Urology, 50: 87-92, 1997.
4. Vincini, F. A., Horwitz, E. M., Gonzalez, J., and Martinez, A. A. Treatment options for localized prostate cancer based on pretreatment serum prostate-specific antigen levels. J. Urol., 158: 319-325, 1997.
5. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
6. Maeda, H., Danel, C., and Crystal, R. G. Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology, 106: 1638-1644, 1994.
7. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluourocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 33-37, 1992.
8. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
9. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276-5281, 1986.
10. Hoganson, D. K., Batra, R. K., Olsen, J. C., and Boucher, R. C. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res., 56: 1315-1323, 1996.
11. Ram, Z., Walbridge, S., Shawker, T., Culver, K. W., Blaese, R. M., and Oldfield, E. H. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg., 81: 256-260, 1994.
12. Kim, J. H., Kim, S. H., Brown, S. L., and Freytag, S. O. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced by HSV-tk gene. Cancer Res., 54: 6053-6056, 1994.
13. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
14. Fick, J., Barker, F. G., Dazin, P., Westphale, E. M., Beyer, E. C., and Israel, M. A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. USA, 92: 11071-11075, 1995.
15. Rogulski, K. R., Kim, J. H., Kim, S. H., and Freytag, S. O. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther., 8: 73-85, 1997.
16. Graham, F. L., and Prevec, L. Methods for construction of adenovirus vectors. Mol. Biotechnol., 3: 207-220, 1995.
17. Graham, F. L., and van der Eb, A. J. A new technique for the assay of infectivity of adenovirus 5 DNA. Virology, 52: 456-467, 1973.
18. Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B., and Graham, F. L. Use of human adenovirus based vectors for antigen expression in animals. J. Gen. Virol., 70: 429-434.
19. Oleson, J. R., Calderwood, S. K., Coughlin, C. T., Dewhirst, M. W., Gerweck, L. E., Gibbs, F. A., and Kapp, D. S. Biological and clinical aspects of hyperthermia in cancer therapy. Am. J. Clin. Oncol., 11: 368-380, 1988.
20. Lee, Y. J., Kim, J. H., Ryu, S., Kim, S. H., Hou, Z., Erdos, G., Cho, J. M., and Corry, P. M. Comparison of heat shock gene expression in mild hyperthermia-sensitive prostatic carcinoma cells and heat-resistant human breast carcinoma cells. J. Therm. Biol., 19: 151-161, 1994.
21. Dahl, G., Miller, T., Paul, D., Voellmy, R., and Werner, R. Expression of functional cell-cell channels from cloned rat liver gap junction complementary DNA. Science (Washington DC), 236: 1290-1293, 1987.
22. Kingston, R. E. Transfection of DNA into eukaryotic cells. In: F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (eds.), Short Protocols in Molecular Biology, pp. 9-3-9-5. New York: John Wiley and Sons, 1992.
23. Rosenthal, N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol., 152: 704-720, 1987.
24. Blackburn, R. V., Galoforo, S., Berns, C. M., Ireland, M., Cho, J. M., Corry, P. M., and Lee, Y. J. Induction of thermal response in murine L929 cells lacking αB-crystallin expression and αB-crystallin expressing L929 transfectants. Mol. Cell. Biochem., 155: 51-60, 1995.
25. Verma, I. M., and Somia, M. Gene therapy: promises, problems and prospects. Nature (Lond.), 389: 239-242, 1997.
26. th ed., pp. 1209-1263. New York: Pergamon Press, 1990.
27. Crumpacker, C. S. Drug therapy. Ganciclovir. N. Engl. J. Med., 335: 721-729, 1996.
28. Halbert, D. N., Cutt, J. R., and Shenk, T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shut off. J. Virol., 56: 250-257, 1985.
29. Overgaard, J. Effect of hyperthermia on malignant cells in vivo. A review and hypothesis. Cancer (Phila.), 39: 2637-2646, 1997.
30. Otte, J. Hyperthermia in cancer therapy. Eur. J. Pediatr., 147: 560-569, 1988.
31. Streffer, C. Aspects of metabolic change after hyperthermia. Recent Results Cancer Res., 107: 7-16, 1988.
32. Ben-Hur, E., Elkind, M. M., and Bronk, B. V. Thermally enhanced radio-response of cultured Chinese hamster cells: inhibition of repair of sublethal damage and enhancement of lethal damage. Radiat. Res., 58: 38-51, 1974.
33. Imler, J. L. Adenoviral vectors as recombinant viral vaccines. Vaccine, 13: 1143-1151, 1995.
34. Gorziglia, M. I., Kadn, M. J., Yei, S., Lim, J., Lee, G. M., Luthra, R., and Trapnel, B. C. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol., 70: 4173-4178, 1996.
35. Amalfitano, A., Begy, C. R., and Chamberlain, J. S. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. USA, 93: 3352-3356, 1996.